APO Research

APO RESEARCH · REPORT

Buprenorphine Hydrochloride Injection

Selected research

Industry Growth & Trends

Global Buprenorphine Hydrochloride Injection Industry Growth and Trends Forecast to 2032

Market perspective

The global Buprenorphine Hydrochloride Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Buprenorphine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Buprenorphine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Buprenorphine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Buprenorphine Hydrochloride Injection include Arevipharma, Faranshimi, Mallinckrodt, Micro Orgo Chem, Noramco, Resonance-labs, Rusan Pharma, Siegfried and Sun Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Buprenorphine Hydrochloride Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Buprenorphine Hydrochloride Injection market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Buprenorphine Hydrochloride Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Buprenorphine Hydrochloride Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Buprenorphine Hydrochloride Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Buprenorphine Hydrochloride Injection Market by Company

Arevipharma

Faranshimi

Mallinckrodt

Micro Orgo Chem

Noramco

Resonance-labs

Rusan Pharma

Siegfried

Sun Pharma

Unichemlabs

Sanofi

Teva

Johnson Matthey

Buprenorphine Hydrochloride Injection Segment by Type

0.3mg / mL

0.6mg / mL

Buprenorphine Hydrochloride Injection Segment by Application

Analgesic

Opioid Antagonist

Buprenorphine Hydrochloride Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Buprenorphine Hydrochloride Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Buprenorphine Hydrochloride Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Buprenorphine Hydrochloride Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Buprenorphine Hydrochloride Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Buprenorphine Hydrochloride Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 0.3mg / mL Table 2. Major Company of 0.6mg / mL Table 3. Global Buprenorphine Hydrochloride Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Buprenorphine Hydrochloride Injection Sales by Type (2021-2026) & (Kg) Table 5. Global Buprenorphine Hydrochloride Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Buprenorphine Hydrochloride Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Buprenorphine Hydrochloride Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Buprenorphine Hydrochloride Injection Price by Type (2021-2026) & (US$/Kg) Table 9. Global Buprenorphine Hydrochloride Injection Sales by Type (2027-2032) & (Kg) Table 10. Global Buprenorphine Hydrochloride Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Buprenorphine Hydrochloride Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Buprenorphine Hydrochloride Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Buprenorphine Hydrochloride Injection Price by Type (2027-2032) & (US$/Kg) Table 14. North America Buprenorphine Hydrochloride Injection Sales by Type (2021-2026) & (Kg) Table 15. North America Buprenorphine Hydrochloride Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Buprenorphine Hydrochloride Injection Sales by Type (2021-2026) & (Kg) Table 17. Europe Buprenorphine Hydrochloride Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Buprenorphine Hydrochloride Injection Sales by Type (2021-2026) & (Kg) Table 19. Asia-Pacific Buprenorphine Hydrochloride Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Buprenorphine Hydrochloride Injection Sales by Type (2021-2026) & (Kg) Table 21. Latin America Buprenorphine Hydrochloride Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Buprenorphine Hydrochloride Injection Sales by Type (2021-2026) & (Kg) Table 23. Middle East and Africa Buprenorphine Hydrochloride Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Buprenorphine Hydrochloride Injection Industry Trends Table 25. Buprenorphine Hydrochloride Injection Industry Drivers Table 26. Buprenorphine Hydrochloride Injection Industry Opportunities and Challenges Table 27. Buprenorphine Hydrochloride Injection Industry Restraints Table 28. Global Buprenorphine Hydrochloride Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Buprenorphine Hydrochloride Injection Revenue Market Share by Company (2021-2026) Table 30. Global Buprenorphine Hydrochloride Injection Sales by Company (2021-2026) & (Kg) Table 31. Global Buprenorphine Hydrochloride Injection Sales Share by Company (2021-2026) Table 32. Global Buprenorphine Hydrochloride Injection Market Price by Company (2021-2026) & (US$/Kg) Table 33. Global Buprenorphine Hydrochloride Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Buprenorphine Hydrochloride Injection Major Company Production Sites and Headquarters Table 35. Global Buprenorphine Hydrochloride Injection Company, Product Type & Application Table 36. Global Buprenorphine Hydrochloride Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Buprenorphine Hydrochloride Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Buprenorphine Hydrochloride Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Buprenorphine Hydrochloride Injection Sales by Region (2021-2026) & (Kg) Table 41. Global Buprenorphine Hydrochloride Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Buprenorphine Hydrochloride Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Buprenorphine Hydrochloride Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Buprenorphine Hydrochloride Injection Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 45. Global Buprenorphine Hydrochloride Injection Sales by Region (2027-2032) & (Kg) Table 46. Global Buprenorphine Hydrochloride Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Buprenorphine Hydrochloride Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Buprenorphine Hydrochloride Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Buprenorphine Hydrochloride Injection Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2027-2032) Table 50. Global Buprenorphine Hydrochloride Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Buprenorphine Hydrochloride Injection Sales by Application (2021-2026) & (Kg) Table 52. Global Buprenorphine Hydrochloride Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Buprenorphine Hydrochloride Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Buprenorphine Hydrochloride Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Buprenorphine Hydrochloride Injection Price by Application (2021-2026) & (US$/Kg) Table 56. Global Buprenorphine Hydrochloride Injection Sales by Application (2027-2032) & (Kg) Table 57. Global Buprenorphine Hydrochloride Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Buprenorphine Hydrochloride Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Buprenorphine Hydrochloride Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Buprenorphine Hydrochloride Injection Price by Application (2027-2032) & (US$/Kg) Table 61. North America Buprenorphine Hydrochloride Injection Sales by Application (2021-2026) & (Kg) Table 62. North America Buprenorphine Hydrochloride Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Buprenorphine Hydrochloride Injection Sales by Application (2021-2026) & (Kg) Table 64. Europe Buprenorphine Hydrochloride Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Buprenorphine Hydrochloride Injection Sales by Application (2021-2026) & (Kg) Table 66. Asia-Pacific Buprenorphine Hydrochloride Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Buprenorphine Hydrochloride Injection Sales by Application (2021-2026) & (Kg) Table 68. Latin America Buprenorphine Hydrochloride Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Buprenorphine Hydrochloride Injection Sales by Application (2021-2026) & (Kg) Table 70. Middle East and Africa Buprenorphine Hydrochloride Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Arevipharma Company Information Table 72. Arevipharma Business Overview Table 73. Arevipharma Buprenorphine Hydrochloride Injection Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 74. Arevipharma Buprenorphine Hydrochloride Injection Product Portfolio Table 75. Arevipharma Recent Development Table 76. Faranshimi Company Information Table 77. Faranshimi Business Overview Table 78. Faranshimi Buprenorphine Hydrochloride Injection Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 79. Faranshimi Buprenorphine Hydrochloride Injection Product Portfolio Table 80. Faranshimi Recent Development Table 81. Mallinckrodt Company Information Table 82. Mallinckrodt Business Overview Table 83. Mallinckrodt Buprenorphine Hydrochloride Injection Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 84. Mallinckrodt Buprenorphine Hydrochloride Injection Product Portfolio Table 85. Mallinckrodt Recent Development Table 86. Micro Orgo Chem Company Information Table 87. Micro Orgo Chem Business Overview Table 88. Micro Orgo Chem Buprenorphine Hydrochloride Injection Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 89. Micro Orgo Chem Buprenorphine Hydrochloride Injection Product Portfolio Table 90. Micro Orgo Chem Recent Development Table 91. Noramco Company Information Table 92. Noramco Business Overview Table 93. Noramco Buprenorphine Hydrochloride Injection Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 94. Noramco Buprenorphine Hydrochloride Injection Product Portfolio Table 95. Noramco Recent Development Table 96. Resonance-labs Company Information Table 97. Resonance-labs Business Overview Table 98. Resonance-labs Buprenorphine Hydrochloride Injection Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 99. Resonance-labs Buprenorphine Hydrochloride Injection Product Portfolio Table 100. Resonance-labs Recent Development Table 101. Rusan Pharma Company Information Table 102. Rusan Pharma Business Overview Table 103. Rusan Pharma Buprenorphine Hydrochloride Injection Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 104. Rusan Pharma Buprenorphine Hydrochloride Injection Product Portfolio Table 105. Rusan Pharma Recent Development Table 106. Siegfried Company Information Table 107. Siegfried Business Overview Table 108. Siegfried Buprenorphine Hydrochloride Injection Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 109. Siegfried Buprenorphine Hydrochloride Injection Product Portfolio Table 110. Siegfried Recent Development Table 111. Sun Pharma Company Information Table 112. Sun Pharma Business Overview Table 113. Sun Pharma Buprenorphine Hydrochloride Injection Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 114. Sun Pharma Buprenorphine Hydrochloride Injection Product Portfolio Table 115. Sun Pharma Recent Development Table 116. Unichemlabs Company Information Table 117. Unichemlabs Business Overview Table 118. Unichemlabs Buprenorphine Hydrochloride Injection Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 119. Unichemlabs Buprenorphine Hydrochloride Injection Product Portfolio Table 120. Unichemlabs Recent Development Table 121. Sanofi Company Information Table 122. Sanofi Business Overview Table 123. Sanofi Buprenorphine Hydrochloride Injection Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 124. Sanofi Buprenorphine Hydrochloride Injection Product Portfolio Table 125. Sanofi Recent Development Table 126. Teva Company Information Table 127. Teva Business Overview Table 128. Teva Buprenorphine Hydrochloride Injection Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 129. Teva Buprenorphine Hydrochloride Injection Product Portfolio Table 130. Teva Recent Development Table 131. Johnson Matthey Company Information Table 132. Johnson Matthey Business Overview Table 133. Johnson Matthey Buprenorphine Hydrochloride Injection Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 134. Johnson Matthey Buprenorphine Hydrochloride Injection Product Portfolio Table 135. Johnson Matthey Recent Development Table 136. North America Buprenorphine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 137. North America Buprenorphine Hydrochloride Injection Sales by Country (2021-2026) & (Kg) Table 138. North America Buprenorphine Hydrochloride Injection Sales Market Share by Country (2021-2026) Table 139. North America Buprenorphine Hydrochloride Injection Sales Forecast by Country (2027-2032) & (Kg) Table 140. North America Buprenorphine Hydrochloride Injection Sales Market Share Forecast by Country (2027-2032) Table 141. North America Buprenorphine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Buprenorphine Hydrochloride Injection Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Buprenorphine Hydrochloride Injection Market Share by Country (2021-2026) Table 144. North America Buprenorphine Hydrochloride Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Buprenorphine Hydrochloride Injection Market Share Forecast by Country (2027-2032) Table 146. Europe Buprenorphine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 147. Europe Buprenorphine Hydrochloride Injection Sales by Country (2021-2026) & (Kg) Table 148. Europe Buprenorphine Hydrochloride Injection Sales Market Share by Country (2021-2026) Table 149. Europe Buprenorphine Hydrochloride Injection Sales Forecast by Country (2027-2032) & (Kg) Table 150. Europe Buprenorphine Hydrochloride Injection Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Buprenorphine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Buprenorphine Hydrochloride Injection Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Buprenorphine Hydrochloride Injection Market Share by Country (2021-2026) Table 154. Europe Buprenorphine Hydrochloride Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Buprenorphine Hydrochloride Injection Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Buprenorphine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Buprenorphine Hydrochloride Injection Sales by Country (2021-2026) & (Kg) Table 158. Asia-Pacific Buprenorphine Hydrochloride Injection Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Buprenorphine Hydrochloride Injection Sales Forecast by Country (2027-2032) & (Kg) Table 160. Asia-Pacific Buprenorphine Hydrochloride Injection Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Buprenorphine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Buprenorphine Hydrochloride Injection Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Buprenorphine Hydrochloride Injection Market Share by Country (2021-2026) Table 164. Asia-Pacific Buprenorphine Hydrochloride Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Buprenorphine Hydrochloride Injection Market Share Forecast by Country (2027-2032) Table 166. Latin America Buprenorphine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 167. Latin America Buprenorphine Hydrochloride Injection Sales by Country (2021-2026) & (Kg) Table 168. Latin America Buprenorphine Hydrochloride Injection Sales Market Share by Country (2021-2026) Table 169. Latin America Buprenorphine Hydrochloride Injection Sales Forecast by Country (2027-2032) & (Kg) Table 170. Latin America Buprenorphine Hydrochloride Injection Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Buprenorphine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Buprenorphine Hydrochloride Injection Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Buprenorphine Hydrochloride Injection Market Share by Country (2021-2026) Table 174. Latin America Buprenorphine Hydrochloride Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Buprenorphine Hydrochloride Injection Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Buprenorphine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Buprenorphine Hydrochloride Injection Sales by Country (2021-2026) & (Kg) Table 178. Middle East and Africa Buprenorphine Hydrochloride Injection Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Buprenorphine Hydrochloride Injection Sales Forecast by Country (2027-2032) & (Kg) Table 180. Middle East and Africa Buprenorphine Hydrochloride Injection Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Buprenorphine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Buprenorphine Hydrochloride Injection Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Buprenorphine Hydrochloride Injection Market Share by Country (2021-2026) Table 184. Middle East and Africa Buprenorphine Hydrochloride Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Buprenorphine Hydrochloride Injection Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Buprenorphine Hydrochloride Injection Distributors List Table 189. Buprenorphine Hydrochloride Injection Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Buprenorphine Hydrochloride Injection Image Figure 2. Global Buprenorphine Hydrochloride Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Buprenorphine Hydrochloride Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Buprenorphine Hydrochloride Injection Sales (2021-2032) & (Kg) Figure 5. 0.3mg / mL Image Figure 6. Global 0.3mg / mL Sales YoY Growth (2021-2032) & (Kg) Figure 7. 0.6mg / mL Image Figure 8. Global 0.6mg / mL Sales YoY Growth (2021-2032) & (Kg) Figure 9. Global Buprenorphine Hydrochloride Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Buprenorphine Hydrochloride Injection Market Share by Type 2025 VS 2032 Figure 11. North America Buprenorphine Hydrochloride Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Buprenorphine Hydrochloride Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Buprenorphine Hydrochloride Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Buprenorphine Hydrochloride Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Buprenorphine Hydrochloride Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Buprenorphine Hydrochloride Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Buprenorphine Hydrochloride Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Buprenorphine Hydrochloride Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Buprenorphine Hydrochloride Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Buprenorphine Hydrochloride Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Buprenorphine Hydrochloride Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Analgesic Image Figure 24. Global Analgesic Sales YoY Growth (2021-2032) & (Kg) Figure 25. Opioid Antagonist Image Figure 26. Global Opioid Antagonist Sales YoY Growth (2021-2032) & (Kg) Figure 27. Global Buprenorphine Hydrochloride Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Buprenorphine Hydrochloride Injection Market Share by Application 2025 VS 2032 Figure 29. North America Buprenorphine Hydrochloride Injection Sales Market Share in Volume by Application in 2025 Figure 30. North America Buprenorphine Hydrochloride Injection Sales Market Share in Value by Application in 2025 Figure 31. Europe Buprenorphine Hydrochloride Injection Sales Market Share in Volume by Application in 2025 Figure 32. Europe Buprenorphine Hydrochloride Injection Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Buprenorphine Hydrochloride Injection Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Buprenorphine Hydrochloride Injection Sales Market Share in Value by Application in 2025 Figure 35. Latin America Buprenorphine Hydrochloride Injection Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Buprenorphine Hydrochloride Injection Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Buprenorphine Hydrochloride Injection Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Buprenorphine Hydrochloride Injection Sales Market Share in Value by Application in 2025 Figure 39. North America Buprenorphine Hydrochloride Injection Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 40. North America Buprenorphine Hydrochloride Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Buprenorphine Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Buprenorphine Hydrochloride Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Buprenorphine Hydrochloride Injection Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 44. Europe Buprenorphine Hydrochloride Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Buprenorphine Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Buprenorphine Hydrochloride Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Buprenorphine Hydrochloride Injection Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 48. Asia-Pacific Buprenorphine Hydrochloride Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Buprenorphine Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Buprenorphine Hydrochloride Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Buprenorphine Hydrochloride Injection Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 52. Latin America Buprenorphine Hydrochloride Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Buprenorphine Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Buprenorphine Hydrochloride Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Buprenorphine Hydrochloride Injection Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 56. Middle East and Africa Buprenorphine Hydrochloride Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Buprenorphine Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Buprenorphine Hydrochloride Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Buprenorphine Hydrochloride Injection Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Buprenorphine Hydrochloride Injection Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 0.3mg / mL
  • 0.6mg / mL
Applications
  • Analgesic
  • Opioid Antagonist
Companies covered
  • Arevipharma
  • Faranshimi
  • Mallinckrodt
  • Micro Orgo Chem
  • Noramco
  • Resonance-labs
  • Rusan Pharma
  • Siegfried
  • Sun Pharma
  • Unichemlabs
  • Sanofi
  • Teva
  • Johnson Matthey

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Buprenorphine Hydrochloride Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Buprenorphine Hydrochloride Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Buprenorphine Hydrochloride Injection Market by Type
  6. 1.3.1 0.3mg / mL
  7. 1.3.2 0.6mg / mL
  8. 1.4 Global Buprenorphine Hydrochloride Injection Market Size by Type
  9. 1.4.1 Global Buprenorphine Hydrochloride Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Buprenorphine Hydrochloride Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Buprenorphine Hydrochloride Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Buprenorphine Hydrochloride Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Buprenorphine Hydrochloride Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Buprenorphine Hydrochloride Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Buprenorphine Hydrochloride Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Buprenorphine Hydrochloride Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Buprenorphine Hydrochloride Injection Industry Trends
  2. 2.2 Buprenorphine Hydrochloride Injection Industry Drivers
  3. 2.3 Buprenorphine Hydrochloride Injection Industry Opportunities and Challenges
  4. 2.4 Buprenorphine Hydrochloride Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Buprenorphine Hydrochloride Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Buprenorphine Hydrochloride Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Buprenorphine Hydrochloride Injection Price (2021-2026)
  4. 3.4 Global Buprenorphine Hydrochloride Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Buprenorphine Hydrochloride Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Buprenorphine Hydrochloride Injection Company, Product Type & Application
  7. 3.7 Global Buprenorphine Hydrochloride Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Buprenorphine Hydrochloride Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Buprenorphine Hydrochloride Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Buprenorphine Hydrochloride Injection Tier 1, Tier 2, and Tier 3
4 Buprenorphine Hydrochloride Injection Regional Status and Outlook
  1. 4.1 Global Buprenorphine Hydrochloride Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Buprenorphine Hydrochloride Injection Historic Market Size by Region
  3. 4.2.1 Global Buprenorphine Hydrochloride Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Buprenorphine Hydrochloride Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Buprenorphine Hydrochloride Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Buprenorphine Hydrochloride Injection Forecasted Market Size by Region
  7. 4.3.1 Global Buprenorphine Hydrochloride Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Buprenorphine Hydrochloride Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Buprenorphine Hydrochloride Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Buprenorphine Hydrochloride Injection by Application
  1. 5.1 Buprenorphine Hydrochloride Injection Market by Application
  2. 5.1.1 Analgesic
  3. 5.1.2 Opioid Antagonist
  4. 5.2 Global Buprenorphine Hydrochloride Injection Market Size by Application
  5. 5.2.1 Global Buprenorphine Hydrochloride Injection Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Buprenorphine Hydrochloride Injection Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Buprenorphine Hydrochloride Injection Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Buprenorphine Hydrochloride Injection Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Buprenorphine Hydrochloride Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Buprenorphine Hydrochloride Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Buprenorphine Hydrochloride Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Buprenorphine Hydrochloride Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Arevipharma
  2. 6.1.1 Arevipharma Company Information
  3. 6.1.2 Arevipharma Business Overview
  4. 6.1.3 Arevipharma Buprenorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Arevipharma Buprenorphine Hydrochloride Injection Product Portfolio
  6. 6.1.5 Arevipharma Recent Developments
  7. 6.2 Faranshimi
  8. 6.2.1 Faranshimi Company Information
  9. 6.2.2 Faranshimi Business Overview
  10. 6.2.3 Faranshimi Buprenorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Faranshimi Buprenorphine Hydrochloride Injection Product Portfolio
  12. 6.2.5 Faranshimi Recent Developments
  13. 6.3 Mallinckrodt
  14. 6.3.1 Mallinckrodt Company Information
  15. 6.3.2 Mallinckrodt Business Overview
  16. 6.3.3 Mallinckrodt Buprenorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mallinckrodt Buprenorphine Hydrochloride Injection Product Portfolio
  18. 6.3.5 Mallinckrodt Recent Developments
  19. 6.4 Micro Orgo Chem
  20. 6.4.1 Micro Orgo Chem Company Information
  21. 6.4.2 Micro Orgo Chem Business Overview
  22. 6.4.3 Micro Orgo Chem Buprenorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Micro Orgo Chem Buprenorphine Hydrochloride Injection Product Portfolio
  24. 6.4.5 Micro Orgo Chem Recent Developments
  25. 6.5 Noramco
  26. 6.5.1 Noramco Company Information
  27. 6.5.2 Noramco Business Overview
  28. 6.5.3 Noramco Buprenorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Noramco Buprenorphine Hydrochloride Injection Product Portfolio
  30. 6.5.5 Noramco Recent Developments
  31. 6.6 Resonance-labs
  32. 6.6.1 Resonance-labs Company Information
  33. 6.6.2 Resonance-labs Business Overview
  34. 6.6.3 Resonance-labs Buprenorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Resonance-labs Buprenorphine Hydrochloride Injection Product Portfolio
  36. 6.6.5 Resonance-labs Recent Developments
  37. 6.7 Rusan Pharma
  38. 6.7.1 Rusan Pharma Company Information
  39. 6.7.2 Rusan Pharma Business Overview
  40. 6.7.3 Rusan Pharma Buprenorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Rusan Pharma Buprenorphine Hydrochloride Injection Product Portfolio
  42. 6.7.5 Rusan Pharma Recent Developments
  43. 6.8 Siegfried
  44. 6.8.1 Siegfried Company Information
  45. 6.8.2 Siegfried Business Overview
  46. 6.8.3 Siegfried Buprenorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Siegfried Buprenorphine Hydrochloride Injection Product Portfolio
  48. 6.8.5 Siegfried Recent Developments
  49. 6.9 Sun Pharma
  50. 6.9.1 Sun Pharma Company Information
  51. 6.9.2 Sun Pharma Business Overview
  52. 6.9.3 Sun Pharma Buprenorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sun Pharma Buprenorphine Hydrochloride Injection Product Portfolio
  54. 6.9.5 Sun Pharma Recent Developments
  55. 6.10 Unichemlabs
  56. 6.10.1 Unichemlabs Company Information
  57. 6.10.2 Unichemlabs Business Overview
  58. 6.10.3 Unichemlabs Buprenorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Unichemlabs Buprenorphine Hydrochloride Injection Product Portfolio
  60. 6.10.5 Unichemlabs Recent Developments
  61. 6.11 Sanofi
  62. 6.11.1 Sanofi Company Information
  63. 6.11.2 Sanofi Business Overview
  64. 6.11.3 Sanofi Buprenorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Sanofi Buprenorphine Hydrochloride Injection Product Portfolio
  66. 6.11.5 Sanofi Recent Developments
  67. 6.12 Teva
  68. 6.12.1 Teva Company Information
  69. 6.12.2 Teva Business Overview
  70. 6.12.3 Teva Buprenorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Teva Buprenorphine Hydrochloride Injection Product Portfolio
  72. 6.12.5 Teva Recent Developments
  73. 6.13 Johnson Matthey
  74. 6.13.1 Johnson Matthey Company Information
  75. 6.13.2 Johnson Matthey Business Overview
  76. 6.13.3 Johnson Matthey Buprenorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Johnson Matthey Buprenorphine Hydrochloride Injection Product Portfolio
  78. 6.13.5 Johnson Matthey Recent Developments
7 North America by Country
  1. 7.1 North America Buprenorphine Hydrochloride Injection Sales by Country
  2. 7.1.1 North America Buprenorphine Hydrochloride Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Buprenorphine Hydrochloride Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Buprenorphine Hydrochloride Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Buprenorphine Hydrochloride Injection Market Size by Country
  6. 7.2.1 North America Buprenorphine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Buprenorphine Hydrochloride Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Buprenorphine Hydrochloride Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Buprenorphine Hydrochloride Injection Sales by Country
  2. 8.1.1 Europe Buprenorphine Hydrochloride Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Buprenorphine Hydrochloride Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Buprenorphine Hydrochloride Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Buprenorphine Hydrochloride Injection Market Size by Country
  6. 8.2.1 Europe Buprenorphine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Buprenorphine Hydrochloride Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Buprenorphine Hydrochloride Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Buprenorphine Hydrochloride Injection Sales by Country
  2. 9.1.1 Asia-Pacific Buprenorphine Hydrochloride Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Buprenorphine Hydrochloride Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Buprenorphine Hydrochloride Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Buprenorphine Hydrochloride Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Buprenorphine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Buprenorphine Hydrochloride Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Buprenorphine Hydrochloride Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Buprenorphine Hydrochloride Injection Sales by Country
  2. 10.1.1 South America Buprenorphine Hydrochloride Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Buprenorphine Hydrochloride Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Buprenorphine Hydrochloride Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Buprenorphine Hydrochloride Injection Market Size by Country
  6. 10.2.1 South America Buprenorphine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Buprenorphine Hydrochloride Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Buprenorphine Hydrochloride Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Buprenorphine Hydrochloride Injection Sales by Country
  2. 11.1.1 Middle East and Africa Buprenorphine Hydrochloride Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Buprenorphine Hydrochloride Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Buprenorphine Hydrochloride Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Buprenorphine Hydrochloride Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Buprenorphine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Buprenorphine Hydrochloride Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Buprenorphine Hydrochloride Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Buprenorphine Hydrochloride Injection Value Chain Analysis
  2. 12.1.1 Buprenorphine Hydrochloride Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Buprenorphine Hydrochloride Injection Production Mode & Process
  7. 12.2 Buprenorphine Hydrochloride Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Buprenorphine Hydrochloride Injection Distributors
  10. 12.2.3 Buprenorphine Hydrochloride Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research